The Near-Perfect Portfolio: Sleep Well During Turbulent Times

02:00pm, Saturday, 11'th Mar 2023 Seeking Alpha
With the economy going through the boom and bust cycles more frequently, the extreme ups and downs of the market are inevitable. Read more here.

3 No-Brainer Dividend Stocks to Buy in March

11:14am, Saturday, 11'th Mar 2023 The Motley Fool
Going with these great dividend stocks is an easy choice.
The stock market is inherently volatile. With the economy going through the boom and bust cycles more frequently, the extreme ups and downs of the market are inevitable. For most conservative investor
Dividend investing happens, whether the stock market is up or down, whether the Fed raises interest rates or lowers. It's all about buying dividend income-producing stocks – the best source of passi

The 4 Dividend Aristocrat Buys For March

03:36pm, Friday, 10'th Mar 2023
"Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." --Kiplinger.com/Investing. 67 Aristocrats screened as of March 8, 2023, repre
Johnson & Johnson's business model is as defensive as they come. Click here to read on two superior low-volatility SWAN alternatives to JNJ stock.

Should You Invest in the Vanguard Health Care ETF (VHT)?

11:20am, Friday, 10'th Mar 2023 Zacks Investment Research
Sector ETF report for VHT
Johnson & Johnson (NYSE: JNJ ) layoffs are on the way as the medical, pharmaceutical, and consumer goods company cuts jobs. These layoffs have Johnson & Johnson cutting 350 jobs at its Auris Health an
J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi have been highlighted in this Industry Outlook article.
Recession is coming and with it plenty of scary headlines about crashing stock prices and financial doom. Low volatility dividend SWANs (sleep-well-at-night) blue chips like JNJ are a great way to rid
Income stocks can supercharge your portfolio's growth in a wide range of market environments.

5 Large Drug Stocks to Watch as Sector Picks Up in 2023

01:00pm, Thursday, 09'th Mar 2023 Zacks Investment Research
Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, J&J (JNJ), Novo Nordisk (NVO), AstraZeneca (AZN), Novartis (NVS), and Sa
Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, J&J (JNJ), Novo Nordisk (NVO), AstraZeneca (AZN), Novartis (NVS), and Sa
Innovative Industrial Properties is still witnessing high rent collection rates and just recorded another year of stunning profits. Johnson & Johnson is preparing for some big changes later this year,

10 Best Consumer Staples ETFs

07:01am, Thursday, 09'th Mar 2023
A consumer staple ETF (exchange-traded fund) is an investment fund that tracks a series of stocks in companies that produce essential goods and services. The definition of a "consumer staple" usually
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE